{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:12:30Z","timestamp":1793729550031,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer has become a growing burden in Pakistan in recent times, posing a\n            significant cause for concern. The World Health Organization has reported a steady\n            increase in the incidence of cancer in Pakistan. According to the present study, breast\n            cancer (24.1%), oral cavity (9.6%), colorectum (4.9%), esophagus (4.2%), and liver\n            cancer (3.9%) were the five most prevalent cancers. Males were more likely to have oral\n            cavity cancer (14.9%), colorectum cancer (6.8%), liver cancer (6.4%), prostate cancer\n            (6.0%), and lung cancer (6.0%). In women (41.6%), breast (6.9%), oral cavity (5.5%),\n            cervix (4.7%), and uterus\u00a0cancer (4.1%) were the most common cancers. Middle-aged people\n            (43.0%) were most likely to develop cancer, followed by seniors (30.0%) and adults\n            (20.0%). Children and adolescents were most likely to develop cancers of the central\n            nervous system (CNS), leukemia (18.7%), and Hodgkin (17.3%), followed by breast, oral\n            cavity, colorectum, and prostate at other ages. Most patients were from Punjab (40.4%)\n            and Sindh (32.2%). Approximately 30.0% of patients were diagnosed at stage III and stage\n            IV. In terms of registered cases, breast cancer, oral cavity cancer, colon cancer,\n            esophagus cancer, and liver cancer are among the highest. In the future, this\n            information may prove useful for assessing the effectiveness of interventions.<\/jats:p>","DOI":"10.1007\/s44197-023-00104-5","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:02:36Z","timestamp":1682434956000},"page":"333-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["RETRACTED ARTICLE: Exploring the Burden of Cancer in Pakistan: An\n         Analysis of 2019 Data"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3442-7216","authenticated-orcid":false,"given":"Muhammad","family":"Tufail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"104_CR1","unstructured":"Organization WH. World Health Organization-WHO. 2000. https:\/\/scholar.google.com\/scholar?cluster=9108096408442063617&hl=en&as_sdt=0,5"},{"issue":"17","key":"104_CR2","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.3390\/cancers13174440","volume":"13","author":"S Libring","year":"2021","unstructured":"Libring S, et al. In vitro magnetic techniques for investigating cancer\n               progression. Cancers. 2021;13(17):4440.","journal-title":"Cancers"},{"issue":"6","key":"104_CR3","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of\n               incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer\n               journal for clinicians. 2018;68(6):394\u2013424.","journal-title":"CA: a cancer journal for clinicians"},{"key":"104_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153698","volume":"91","author":"A Sheik","year":"2021","unstructured":"Sheik A, et al. The anti-cancerous activity of adaptogenic herb\n               Astragalus membranaceus. Phytomedicine. 2021;91: 153698.","journal-title":"Phytomedicine"},{"issue":"4","key":"104_CR5","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/hex.13289","volume":"24","author":"CH Wong","year":"2021","unstructured":"Wong CH, et al. Prioritizing Chinese medicine clinical research\n               questions in cancer palliative care from patient and caregiver perspectives. Health\n               Expect. 2021;24(4):1487\u201397.","journal-title":"Health Expect"},{"key":"104_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1200\/GO.21.00029","volume":"7","author":"M Abdel-Wahab","year":"2021","unstructured":"Abdel-Wahab M, et al. Global radiotherapy: current status and future\n               directions\u2014white paper. JCO Glob Oncol. 2021;7:827\u201342.","journal-title":"JCO Glob Oncol"},{"issue":"4","key":"104_CR7","first-page":"973","volume":"5","author":"\u00c7 Altunal","year":"2022","unstructured":"Altunal \u00c7, \u015eahiner IT. The relationship of breast cancer deaths with\n               age groups and urbanization of the population: a multi-country analysis. J Health Sci\n               Med. 2022;5(4):973\u20136.","journal-title":"J Health Sci Med"},{"issue":"10","key":"104_CR8","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1177\/0300060518791090","volume":"46","author":"D Wen","year":"2018","unstructured":"Wen D, et al. Urban\u2013rural disparity in colorectal cancer incidence and\n               increasing trend in relation to socioeconomic development and urbanization in China.\n               J Int Med Res. 2018;46(10):4181\u201396.","journal-title":"J Int Med Res"},{"issue":"9","key":"104_CR9","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/cells10092269","volume":"10","author":"E Laconi","year":"2021","unstructured":"Laconi E, et al. Aging and cancer: the waning of community bonds.\n               Cells. 2021;10(9):2269.","journal-title":"Cells"},{"issue":"6","key":"104_CR10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cancers13061400","volume":"13","author":"L Berben","year":"2021","unstructured":"Berben L, et al. Cancer and aging: two tightly interconnected\n               biological processes. Cancers. 2021;13(6):1400.","journal-title":"Cancers"},{"key":"104_CR11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2147\/JMDH.S311225","volume":"14","author":"Y Yonenaga","year":"2021","unstructured":"Yonenaga Y, et al. Impact of physical inactivity on the risk of\n               disability and hospitalization in older patients with advanced lung cancer. J\n               Multidiscip Healthc. 2021;14:1521.","journal-title":"J Multidiscip Healthc"},{"key":"104_CR12","unstructured":"Minihan AK, et al. Proportion of cancer cases attributable to physical\n               inactivity by US state, 2013\u20132016. Med Sci Sports Exerc. 2021. https:\/\/scholar.google.com\/scholar?hl=en&as_sdt=0%2C5&q=Minihan+AK%2C+et+al.+Proportion+of+cancer+cases+attributable+to+physical+inactivity+by+US+state%2C+2013%E2%80%932016.+Med+Sci+Sports+Exerc.+2021&btnG="},{"issue":"1","key":"104_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13053-021-00199-6","volume":"19","author":"A Daniele","year":"2021","unstructured":"Daniele A, et al. Can harmful lifestyle, obesity and weight changes\n               increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini\n               review. Hered Cancer Clin Pract. 2021;19(1):1\u20138.","journal-title":"Hered Cancer Clin Pract"},{"key":"104_CR14","doi-asserted-by":"crossref","unstructured":"Li X, et al. Accelerated aging mediates the associations of unhealthy\n               lifestyles with cardiovascular disease, cancer, and mortality: two large prospective\n               cohort studies. medRxiv, 2022. https:\/\/scholar.google.com\/scholar?hl=en&as_sdt=0%2C5&q=Air+pollution%2C+genetic+factors+and+the+risk+of+lung+cancer&btnG=","DOI":"10.1101\/2022.05.18.22275184"},{"issue":"7","key":"104_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.202011-4063OC","volume":"204","author":"Y Huang","year":"2021","unstructured":"Huang Y, et al. Air pollution, genetic factors, and the risk of lung\n               cancer: a prospective study in the UK Biobank. Am J Respir Crit Care Med.\n               2021;204(7):817\u201325.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"104_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/jpm11010060","volume":"11","author":"M Sima","year":"2021","unstructured":"Sima M, et al. The impact of air pollution exposure on the MicroRNA\n               machinery and lung cancer development. J Personal Med.\n               2021;11(1):60.","journal-title":"J Personal Med"},{"issue":"6","key":"104_CR17","first-page":"425","volume":"68","author":"KD Miller","year":"2018","unstructured":"Miller KD, et al. Cancer statistics for hispanics\/latinos, 2018. CA:\n               Cancer J Clinic. 2018;68(6):425\u201345.","journal-title":"CA: Cancer J Clinic"},{"key":"104_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-030-63749-1_2","volume":"218","author":"C Weiss","year":"2021","unstructured":"Weiss C. One in four dies of cancer. Questions about the epidemiology\n               of malignant tumours. Recent Results Cancer Res. 2021;218:15\u201329.","journal-title":"Recent Results Cancer Res"},{"issue":"6","key":"104_CR19","first-page":"452","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, et al. Cancer statistics for adults aged 85 years and\n               older, 2019. CA: Cancer J Clinic. 2019;69(6):452\u201367.","journal-title":"CA: Cancer J Clinic"},{"key":"104_CR20","first-page":"2","volume":"9","author":"A Bilal","year":"2021","unstructured":"Bilal A, Naveed N, Haider M. A brief note on cancer and its treatment.\n               Occup Med Health Aff. 2021;9:2.","journal-title":"Occup Med Health Aff"},{"issue":"5","key":"104_CR21","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, et al. Cancer incidence and mortality worldwide: sources,\n               methods and major patterns in GLOBOCAN 2012. Int J Cancer.\n               2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"1","key":"104_CR22","doi-asserted-by":"publisher","first-page":"1288773","DOI":"10.1080\/2331205X.2017.1288773","volume":"4","author":"MR Sarwar","year":"2017","unstructured":"Sarwar MR, Saqib A. Cancer prevalence, incidence and mortality rates in\n               Pakistan in 2012. Cogent Med. 2017;4(1):1288773.","journal-title":"Cogent Med"},{"key":"104_CR23","doi-asserted-by":"crossref","unstructured":"Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer.\n               Ann Glob Health, 2019;85(1). https:\/\/mednexus.org\/doi\/full\/10.1097\/CM9.0000000000001474","DOI":"10.5334\/aogh.2419"},{"issue":"07","key":"104_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, et al. Changing profiles of cancer burden worldwide and in\n               China: a secondary analysis of the global cancer statistics 2020. Chin Med J.\n               2021;134(07):783\u201391.","journal-title":"Chin Med J"},{"issue":"1","key":"104_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-6667-7","volume":"19","author":"S Saeed","year":"2019","unstructured":"Saeed S, et al. Cancer and how the patients see it; prevalence and\n               perception of risk factors: a cross-sectional survey from a tertiary care centre of\n               Karachi, Pakistan. BMC Pub Health. 2019;19(1):1\u20137.","journal-title":"BMC Pub Health"},{"issue":"7","key":"104_CR26","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.21037\/tau-20-1053","volume":"10","author":"Y Lyou","year":"2021","unstructured":"Lyou Y, Dorff TB. Hormonal manipulation in androgen signaling: a\n               narrative review on using novel androgen therapy agents to optimize clinical outcomes\n               and minimize side effects for prostate cancer patients. Transl Androl Urol.\n               2021;10(7):3199.","journal-title":"Transl Androl Urol"},{"issue":"6","key":"104_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its\n               molecular characteristics, screening, treatment, and prognosis. Breast Cancer.\n               2021;28(6):1167\u201380.","journal-title":"Breast Cancer"},{"issue":"9","key":"104_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad F, Cherukuri MK, Choyke PL. Metabolic reprogramming in prostate\n               cancer. Br J Cancer. 2021;125(9):1185\u201396.","journal-title":"Br J Cancer"},{"key":"104_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2022.821598","volume":"13","author":"Z Elkoshi","year":"2022","unstructured":"Elkoshi Z. Cancer and autoimmune diseases: a tale of two immunological\n               opposites? Front Immunol. 2022;13:71.","journal-title":"Front Immunol"},{"issue":"1","key":"104_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14309\/ajg.0000000000001525","volume":"117","author":"MD Jensen","year":"2022","unstructured":"Jensen MD, et al. Increased cancer risk in autoimmune hepatitis: a\n               Danish nationwide cohort study. Am J Gastroenterol.\n               2022;117(1):129\u201337.","journal-title":"Am J Gastroenterol"},{"issue":"24","key":"104_CR31","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1038\/sj.onc.1206528","volume":"22","author":"MJ Ferber","year":"2003","unstructured":"Ferber MJ, et al. Integrations of the hepatitis B virus (HBV) and human\n               papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in\n               liver and cervical cancers. Oncogene. 2003;22(24):3813\u201320.","journal-title":"Oncogene"},{"key":"104_CR32","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.gastro.2004.09.018","volume":"127","author":"M Yu","year":"2004","unstructured":"Yu M, Yuan J. Environmental factors and risk for hepatocellular\n               carcinoma. Gastroenterology. 2004;127:S72\u20138.","journal-title":"Gastroenterology"},{"key":"104_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fgene.2012.00268","volume":"3","author":"MT Dorak","year":"2012","unstructured":"Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an\n               inadequately addressed issue. Front Genet. 2012;3:268.","journal-title":"Front Genet"},{"issue":"4","key":"104_CR34","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","volume":"18","author":"MB Cook","year":"2009","unstructured":"Cook MB, et al. sex disparities in cancer incidence by period and age.\n               Cancer Epidemiol Biomark Prev. 2009;18(4):1174\u201382.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"104_CR35","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","volume":"20","author":"MB Cook","year":"2011","unstructured":"Cook MB, et al. Sex disparities in cancer mortality and survival.\n               Cancer Epidemiol Biomark Prev. 2011;20(8):1629\u201337.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"104_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ctrv.2006.11.003","volume":"33","author":"RD Barr","year":"2007","unstructured":"Barr RD. Common cancers in adolescents. Cancer Treat Rev.\n               2007;33(7):597\u2013602.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"104_CR37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/oxfordjournals.bmb.a011589","volume":"52","author":"IJ Lewis","year":"1996","unstructured":"Lewis IJ. Cancer in adolescence. Br Med Bull.\n               1996;52(4):887\u201397.","journal-title":"Br Med Bull"},{"issue":"1","key":"104_CR38","first-page":"39","volume":"8","author":"S Khazaei","year":"2017","unstructured":"Khazaei S, et al. Incidence rate and distribution of common cancers\n               among Iranian children. Middle East J Cancer. 2017;8(1):39\u201342.","journal-title":"Middle East J Cancer"},{"issue":"S7","key":"104_CR39","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1002\/bem.20149","volume":"26","author":"PA McKinney","year":"2005","unstructured":"McKinney PA. Central nervous system tumours in children: Epidemiology\n               and risk factors. Bioelectromagnetics. 2005;26(S7):S60\u20138.","journal-title":"Bioelectromagnetics"}],"updated-by":[{"DOI":"10.1007\/s44197-025-00483-x","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000}}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-023-00104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-023-00104-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-023-00104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:02:48Z","timestamp":1762286568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-023-00104-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1007\/s44197-023-00104-5","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s44197-025-00483-x","URL":"https:\/\/doi.org\/10.1007\/s44197-025-00483-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Shanxi University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participant consent was not required in this registry-based study, as\n               the data used were de-identified and anonymized, and did not contain personally\n               identifiable information (PII). The study adhered to applicable regulations and\n               ethical guidelines, and privacy and confidentiality of the data were maintained\n               throughout the research process.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}